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ABSTRACT 
Balakrishnan, Anuranjani. M.S., Microbiology and Immunology Graduate Program, 
Wright State University, 2018. Effects of Voluntary Physical Rehabilitation on 
Neurogenesis in SVZ and Functional Recovery after Ischemic Stroke. 
 
Stroke is the leading cause of long-term disability and 87% of all strokes are due to 
ischemic strokes. In this current study, we examined whether voluntary physical 
rehabilitation can influence neurogenesis (measured by Doublecortin) in the 
subventricular zone and show improved motor functional recovery in 10-12 month 
female rats after ischemia. We saw a significant increase in the neurogenesis 
(measured by doublecortin) of all three regions (anterior, middle and posterior) of 
SVZ in the rehab animals compared to control group when using a two-way variance 
ANOVA test, although we were unable to see significant differences in paired t-tests 
of similar regions for control and rehab animals. The control animals showed a 
significant increase in contralateral functional recovery of 56% with rehab animals 
displaying a recovery of 23%. These findings suggest that the physical rehabilitation 
showed increased neurogenesis in the SVZ but did not translate to greater 
contralateral functional recovery.  
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1. INTRODUCTION 
 
1.1 STROKE: 
Stroke is the leading cause of long-term disability. Nearly 800,000 
approximately (795,000) people in the United States are affected by stroke every year 
and about 31 percent have reported repeating attacks (1). There are nearly 7 million 
stroke survivors in the U.S and stroke is the fifth leading cause of death in the U.S (2).  
 About 87% of all strokes are due to ischemic stroke (2), and it is 
characterized by the occlusion of a brain arterial blood vessel (4). Clinical treatments 
have advanced in the acute time window but long-term treatment remains limited. 
However, many of the research studies are focusing on approaches to improve the 
mechanism of brain repair after a stroke to enhance adult neurogenesis (5).  
The main types of strokes are ischemic, hemorrhage and transient ischemic 
attacks (TIA). Each type of stroke is briefly explained in detail below. 
 
1.2 ISCHEMIC STROKE: 
 Ischemic stroke occurs when the blood supply to the brain is obstructed which 
causes brain cells to die, deprived of oxygen supply. This can be caused by the fatty 
deposits lining the blood vessel, a condition called arthrosclerosis. There are two 
basic types of ischemic stroke caused by these fatty acid deposits: cerebral thrombosis 
and cerebral embolism (8). 
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Figure 1: This image represents an Ischemic stoke showing an obstructed artery to 
the brain (8). 
 
Cerebral thrombosis usually occurs when the artery within the brain is blocked 
by a blood clot (thrombus). This event occurs to 50% of all the stroke victims. 
Cerebral embolism is also a blood clot but formed somewhere else in the circulatory 
system, usually the heart which then carries the emboli through the bloodstream and 
travels to the brain’s blood vessels until it becomes lodged. Another risk factor of 
embolism can be due to irregular heartbeat known as arterial fibrillation (8).  
 
1.3 HEMORRHAGIC STROKE:  
Hemorrhagic stroke accounts only for 13% of all strokes. However, 40% of all 
stroke deaths are due to hemorrhagic stroke (6). The most common causes of 
hemorrhage stroke include burst aneurysm, arteriovenous malfunction (AVM), 
arteriolar hypertensive diseases, blood thinners and head injury (7).  
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Figure: 2 The image shows the hemorrhagic stroke of ruptured cerebral aneurysm 
(8). 
 
Hemorrhagic stroke occurs when a weakened vessel ruptures and bleeds into 
the surrounding brain (1). The sudden accumulation of blood increases pressure and 
compresses the brain tissue. There are two types of hemorrhagic stroke, intracerebral 
hemorrhage (ICH) and subarachnoid hemorrhage (SAH). ICH occurs when a diseased 
vessel ruptures and bleeds into the tissue deep inside the brain. The common cause of 
ICH is due to high blood pressure (hypertension). SAH occurs when a blood vessel 
ruptures on the surface of the brain and the surrounding brain (the subarachnoid 
space) are rapidly filled with blood. This can lead to unconsciousness and death due 
to pressure buildup outside the brain. To reduce the risk of subsequent fatal 
hemorrhage, endovascular coil embolization is performed as a surgical method. 
However, there are only few effective options to treat the neurological dysfunction 
caused by the hemorrhagic stroke (9). 
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1.4 TRANSIENT ISCHEMIC ATTACKS: 
 Transient ischemic attacks (TIA) are often known as warning stroke or mini-
stroke. They represent a warning of an impending ischemic stroke (10). TIA occurs 
when an artery is blocked for a short period. The blockage may dissolve on its own by 
the anticoagulant (blood thinners) in the blood. Approximately 15% of all strokes are 
led by TIAs. Unlike a stroke, there is no enduring damage to the brain, when a TIA is 
over. 
 
1.5 CURRENT TREATMENTS FOR STROKE:  
 The only FDA approved treatment for ischemic stroke is thrombolytic tissue-
type plasminogen activator (tPA) (1). It works by dissolving the blood clot and 
improves blood flow to the brain. Treatment within 3 to 4.5 hours of stroke onset 
increases the potential benefit. Due to its time constraints and post-stroke 
complications including intracranial hemorrhage, if the treatment is given after this 
time period, only 5-8% of ischemic stroke patients are eligible for the treatment (1,64-
66).  
 Mechanical thrombectomy is a surgical treatment, which involves physical 
removal of blood clot via stent retriever. This procedure is performed within 6 hours 
after stroke onset, but beneficial if done within 24 hours of onset (1). Furthermore, 
other current approaches for stroke therapeutics includes magnetic resonance-guided 
focused ultrasound, neuroprotection (acute), cell replacement therapies, endogenous 
stem cells, exogenous stem cells, stereotactic radiotherapy, optogenetic stimulation, 
transcranial magnetic stimulation, PSD-95, hypothermia, induced stem cells, 
modulation of circuits (recovery) (68). 
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1.6 POST-STROKE NEUROGENESIS:  
 Many experimental studies demonstrate the formation of new neurons in the 
stroke damaged adult brain. The neural stem progenitor cells (NSPC) are localized 
primarily in two regions: the subventricular zone (SVZ) of the lateral ventricles and 
the subgranular zone (SVG) of the hippocampus (11). In the SVZ, the neural 
progenitor cells migrate through the rostral migratory stream and differentiate into 
neurons in the olfactory bulb, whereas in the SGZ the NSPCs integrate into the neural 
network as granule cells of the hippocampus (12). A bulk of promising research 
studies demonstrates an increase in the proliferation of endogenous neural stem cells 
(NSC) during an ischemic stroke (13). During an incident of brain ischemia, injury or 
neurodegenerative damages, the migrating new neuroblast escapes from the migratory 
pathway and are drawn towards the impaired site to repair and regenerate (15-18). 
Various exogenous, endogenous modulators can alter post-stroke neurogenesis, 
including growth factors like brain-derived neurotropic factor (BDNF) (14).  
 
1.7 NEUROGENESIS IN THE SVZ: 
 Most of the newly formed neurons are formed in the subventricular zone of 
the brain. It is said that SVZ sustains a pool of neural progenitor cells (NPC) that 
regularly replaces with neurons in the olfactory bulb. While in the case of 
neurodegenerative disorders, the proliferation of NPCs can be substantially 
upregulated or downregulated in the SVZ (19). It was reported that the number of 
proliferating cells significantly increased in the ipsilateral SVZ by 2-14 days with a 
peak at 7 days after an ischemic attack. In addition, SVZ proliferation showed a 
similar increase in the olfactory bulb neurons at 14 days and followed by a reduction 
28 days after a stroke (5,20,14). Thus understanding the role of endogenous NPCs in 
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the subventricular zone can aid in analyzing neurogenesis at the site of injury and 
potentially benefit from the stroke recovery (21). 
 
 
 
 
 
 
 
 
 
 
Figure 3: This figure shows the endogenous NPCs differentiate and migrate from the 
SVZ to the area of ischemia (21). 
 
1.8 NEURONAL MARKERS: 
 In adult neurogenesis, various markers are expressed in the different 
timeframes of neurogenesis. The markers for proliferating cells are ki-67, 
phosphohistone h3 (ph3), mini chromosome maintenance 2 (MCM2), proliferating 
cell nuclear antigen (PCNA). Moreover, markers specific for neuronal lineage are 
doublecortin (DCX), polysialylated embryonic form of the neural cell adhesion 
molecule (PSA-NCAM), calretinin, neurogenic differentiation (NEUROD), T-box 
brain gene 2 (TBR-2). In addition, neuronal markers specific for early stages of 
neurogenesis are nestin, glial fibrillary acidic protein (GFAP), SOX-2 and paired box 
gene 6 (PAX-6) (22-25). 
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1.9 DOUBLECORTIN: 
 Doublecortin (DCX) is a microtubule-associated protein, which facilitates 
polymerization of microtubules. DCX is known as a marker for adult neurogenesis, 
also expressed in newly formed neurons and migrating neuroblasts (25-27). Studies 
have shown the presence of DCX cells with the morphology of migrating neuroblasts 
in the SVZ, RMS and olfactory bulbs (23). The morphology of DCX expressing cells 
in the SVZ was mostly bipolar with short processes. DCX is also used to label 
neuronal progenitor cells and early immature neurons (28,29). Furthermore, DCX 
positive cells are specific to newly formed neurons because they express early 
neuronal antigens but lack antigens specific to undifferentiated cells, glial cells and 
apoptotic cells (30).  
 DCX immunoreactive cells are highly expressed over 2-3 week after the 
ischemic injury but decrease gradually to become NeuN and continue into maturation 
process (31). Studies have shown that increasing number of DCX cells in the adult 
brain is predominantly correlated with two factors; enhanced voluntary physical 
activity and experimentally induced epileptic seizure. However, there is a decrease in 
the expression of DCX cells and neurogenesis in correspondence to ageing (32-36). 
Thus, the transient expression of DCX indicates that it could be an applicable marker 
for measuring the modulation of adult neurogenesis and may provide substitute to 
BrdU labeling (28), because BrdU can falsely label any cell with injured DNA as a 
cell that is undergoing mitosis. 
 
 
1.10 POST-STROKE REHABILITATION: 
 Due to functional disability and limitations of post-stroke treatment, stroke 
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rehabilitation program is only the potential treatment for the majority of stroke 
patients (37,38). The objective of the post-stroke rehabilitation program is to improve 
activities of daily living and to regain independence (37,39). Many research studies 
have shown voluntary exercise and enriched environment can predominantly increase 
neurogenesis after cerebral ischemia, although various studies show neurogenesis on 
different regions of the brain (40-45). Some studies show that post-ischemic exercise 
can enhance neurogenesis in the SVZ, but not in dentate gyrus (DG) (46). In contrast, 
there are studies that show increased levels of neurogenesis in the DG after voluntary 
exercise, but not in the SVZ (41). 
 Furthermore, voluntary exercise can influence all phases of neurogenesis such 
as cell proliferation, differentiation and survival (47-50). It has been evident that the 
time-limited window is crucial for rehabilitation and neuroplasticity (58-61). 
Voluntary exercise delivered within first few weeks after stroke onset can potentially 
aid in the sensorimotor recovery by reducing infarct volume and stimulating brain 
organization (51-52,56-57). In addition, voluntary exercise and environment 
enrichment has proven to increase the levels of BDNF (63). The elevated levels of 
BDNF following exercise enhance recovery and reduce depression like behavior in 
chronic and sub acute patients (52-55,62). Finally, physical exercise has not only 
proven to attenuate motor dysfunction but also showed enhanced neuroplasticity.  
 
1.11 EFFECTS OF FEMALE SEX HORMONE ON ISCHEMIC STROKE: 
 Studies have shown that, approximately 40,000 more women are affected by 
stroke every year (68). The chances of cardiovascular diseases and stroke are higher 
in women after menopause (69-73). This gender difference can be related to 
neuroprotective roles of estrogen, a female sex hormone responsible in reproductive 
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function and sex characteristics in females (74). In addition, researchers have shown 
strong evidence suggesting that estrogen may have a neuroprotective and therapeutic 
function in stroke (75). Experimental studies using MCAO models of stroke has 
demonstrated that female rats have less brain damage compared to the male rats. To 
overcome this problem in animal models, overiectomy was performed to equalize the 
results (76-77). In contrast to numerous studies that showed beneficial role of 
estrogen in preventing stroke in early aged women, the Women’s Health Initiative 
(WHI) trial demonstrated that hormonal replacement therapy (HRT) containing 
estrogen and progestin increased the risk of stroke and heart disease in women (78-
85). Researchers argue that the discrepancies between studies may have resulted due 
to critical parameters like dosage, timing, route of administration (86-87). In addition, 
it might have resulted from the alterations in the timing of estrogen administration in 
relation to perimenopausal (75,87). 
 
1.12 HYPOTHESES: 
 Increased neurogenesis in the subventricular zone (measured by doublecortin) will 
significantly lead to functional recovery following ischemic stroke.  
 We also hypothesized that rehabilitation after stroke induction will increase 
functional recovery.  
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II. MATERIALS AND METHODS 
 
2.1 ETHICS STATEMENT: 
 All experimental procedures were carried out in accordance with the Wright 
State University Institutional Care and Use Committee (IACUC). Female Sprague 
Dawley outbred retired rats obtained from Harlan Laboratories, Indianapolis, 
Indiana were used in the study. 
 
2.2 ANIMALS & HOUSING CONDITIONS: 
 According to stroke studies, more women are affected by stroke each year 
than men (68). Female rats ranging 10-12 months of age were chosen in this study 
to mimic the older women suffering from stroke attacks. In addition, adult rats 
mirror the neurological properties of human stroke patients to make precise 
comparison (88). There were twenty-four rats each grouped into (N=12 control) 
and (N=12 rehabilitation). The animals were housed in individual cages and 
placed in 952cm2 hanging shoeboxes with wire lids. They were on a 12-h 
light/dark cycle and maintained at a room temperature of 22  2°C. All rats were 
fed Harlan Teklad rodent chow throughout the experiment.  
 
2.3 MONTOYA STAIRCASE: 
 Montoya staircase was used as a pre-stroke training to evaluate the 
forepaw ability (to reach with the left or right forepaw independently). Montoya 
staircase can assess reaching and grasping motor function and provides a sensitive
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and quantitative measurement of skilled reaching in rats for each limb separately  
(89). The staircase apparatus has been widely used in animal models to evaluate 
unilateral forelimb deficits in ischemic and hemorrhage stroke models (90). The 
staircase apparatus is made of the Plexiglas and consist of a raised central platform 
with seven bilateral graded steps on each side. The rats can climb onto the central 
platform and reach for the small food pellets which is placed on every step. The 
apparatus is designed in such a way that rats can retrieve pellets from the right steps 
using the right forelimb and the left steps using the left forelimb. The rats cannot turn 
around in the platform or retrieve the dropped pellets from the floor (91). In this 
study, a mixture of plain and maple extract coated sucrose pellets were used to lure 
rats to pick up pellets, with the scent of maple extract attracting the rats. In each 
staircase three pellets were placed in the well, a total of 21 pellets placed on both 
sides of the staircase. 
 
2.4 TRAINING: 
 The rats must be trained properly in the Montoya staircase apparatus before 
surgery for dependable post-stroke data. The rats were trained on a daily basis during 
the dark-phase for 1.5 weeks prior to the surgery. During the training, the rats were 
placed in the box for 15 min and then returned to their home cages. The amount of 
pellets retrieved by each rat from the wells was noted to determine the pre-stroke 
function. The highest number from the last three trials was recorded as the pre-stroke 
function. The minimum reaching performance for the animals to be considered for the 
post-stroke analysis is to retrieve at least 9 pellets out of 21 from the staircase. The 
rats that did not retrieve 9 pellets by the end of the training were excluded from the 
post-stroke training because their forelimb deficit could not be reliably measured (rats 
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can pick up pellets from the first well and possibly the second well with their tongues; 
they must use their forelimb for the third well).  We prefer to get a training level of 15 
pellets, with rats retrieving from 5 wells, as ensures the forelimbs are being used and 
their loss will show up after the stroke. The rats were tested on the staircase to record 
their initial functional deficit at 3-5 days of post-stroke and every 30 days for 
functional recovery. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Image showing Montoya staircase apparatus during the training 
 
2.5 DIET RESTRICTION: 
 The rats were placed on a diet restriction to ameliorate the results of pre-stroke 
and post-stroke training. The amount of ad lib feed was restricted to 15% of their 
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daily intake. This was calculated by the amount of initial ad lib chow given to each rat 
and then subtracted from the amount of remaining food that was left in the feeder for 
each day. The rats were carefully observed and were weighed every three days until 
the end of the training. The rats were fasted overnight before the day of the training 
and were fed restricted diet until the training was completed. The rats only lost about 
10% of their body weight during the week & ½ training period and did not suffer 
from significant weight loss during any of the post-surgical testing periods (3 days). 
 
2.6 INDUCTION OF STROKE: 
 The stroke was induced to the right hemisphere of all rats in this study 
(Animal approval protocol: AUP 1015), which caused impairment to the left forelimb. 
The surgery was performed using a stereotactic apparatus (Stoelting Co., USA) 
(92,93). The stroke was stimulated via stereotactic injection of a vasoconstrictive 
peptide, endothelin -1. 
 Prior to the surgery, each animal was brought individually into the surgical 
room and was placed into a glass chamber, with 5% of isoflurane for 4 minutes to 
induce anesthesia. Once the animal was sedated, the top of the head was shaven and 
Puralube ointment was applied to their eyes to keep them from drying out and 
hydrated during the surgery. The animal was then placed onto the stereotactic 
apparatus using non-traumatic ear bars and was administered with 2.5% of isoflurane 
throughout the surgery with an anesthesia mask. The animal’s foot or tail was pinched 
as a retraction reflex method and the respiration rate and the color of the skin was 
observed to check their effectiveness of anesthesia during the surgery. The surgical 
site was sterilized with povidone-iodine, then with 70% ethanol and again with 
povidone-iodine. A small incision was made using the scissors on the scrubbed area 
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of the head and bupivicane (analgesic) was applied on the incision area. The blood 
from the incision area was cleaned and bregma was positioned on the skull using the 
fine point marker. The bregma was aligned with the burr bit in a micro drill and 
bregma co-ordinates were recorded using the stereotactic apparatus. 
Table: 1 Co-ordinates of stroke induction 
 
The forelimb cortex on the right hemisphere was marked using bregma co-
ordinates, the identified location are shown in the table 1. Small burr holes were 
drilled at two positions. Next, the micro drill was removed and the Hamilton syringe 
was attached to the stereotactic apparatus. The syringe was filled with a total of 3μl of 
endothelin-1 (Human/porcine, EMD chemicals). At each hole, the endothelin (1.5 
micro liters) was slowly injected at the pace of 0.1 microliter every 10 seconds at a 
depth of 2 milliliter. After the endothelin administration at both sites, the Hamilton 
syringe was removed from the apparatus and the surgical site was sutured. Then the 
sutured site was applied with povidone iodine and the animal was injected with 2 ml 
of saline subcutaneously. Once the animal regained consciousness, they were taken 
back to their cages with heating pad to keep them warm. The animal was closely 
monitored until it regained consciousness and locomotion was observed. The animal 
was taken back to its housing area and the next animal was prepared for the surgery. 
 First hole Second hole 
Anterior posterior 
position from bregma 
0mm 1.5mm 
Medial lateral position 
from bregma 
2.5mm 2.5mm 
	 15	
All the rats were given moist chow for three days post-stroke and normal diet was 
given after that.  
 
2.7 POST-STROKE TREATMENT: 
 The rats that were in the vehicle group received 4 grams of Pillsbury cookie 
dough for 60 days post-stroke, beginning 24 hours after stroke surgery. The rat chow 
diet was restricted only during staircase training, rest of the days they were fed with 
ad lib rat chow. The weight of the rats was regularly monitored each week. 
 
2.8 VOLUNTARY PHYSICAL REHABILITATION: 
 The shelves were hung outside the cages with about 10-12 grams of peanut 
butter. The rehab shelves were hung in such a way that the rats were only able to use 
their left forelimb (contralateral limb) to grab the peanut butter. Prior to the surgery, 
the shelves with peanut butter were hung and the rats that consumed the peanut butter 
were chosen for the rehab study. 
 At the beginning of 8 days post-ischemia, the rats that were selected for the 
rehab study started their voluntary physical rehabilitation by consuming peanut butter 
from the hanging shelves. The functional recovery was measured and analyzed upon 
the daily movement of the rat’s contralateral limb. Every morning, the amount of 
peanut butter consumed by the rats were weighed and recorded and this routine was 
followed for a total of 52 days. 
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Figure: 5 This image is showing the rehab hanging shelves with peanut butter and 
the rat using its contralateral limb (left forelimb) to grab the peanut butter. 
 
2.9 MEASURING ARM SWIPES: 
 The amount of peanut butter a rat takes up in a single swipe using its forelimb 
was calculated to determine the number of arm swipes a rat achieved everyday during 
the rehab study. This was calculated by weighing the peanut butter shelve before 
hanging them into the cage and reweighed it again when the rat had attained 
5,10,15,20 arm swipes and the average of amount peanut butter a rat would attain in a 
single swipe was calculated. For example, if a rat had attained 0.30 grams of peanut 
butter with 15 arm swipes, then the mean value of a single swipe would be 0.02 grams 
for that rat. Overall we attained values from at least 15 rats to determine the mean 
value of peanut butter picked up per arm swipe. 
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2.10 POST-STROKE STAIRCASE FUNCTIONAL TESTING: 
  Montoya staircase functional testing began at 3-5, 28-30, 58-69 days post-
stroke. The baseline deficit was determined on the 3-5 days post-stroke and the 
baseline function pre-stroke was calculated from the last three days of pre-stroke 
training. For example, if the rat retrieved 15L (left forepaw) and 16R (right forepaw) 
on the first day, 12L and 13R the next day, 14L and 17R on the final day, then the pre-
stroke baseline function for the left forepaw is 12L and for the right forepaw is 17R. 
The contralateral and the ipsilateral functional deficit were calculated as shown below. 
  
 
 
  
 
 
 
 
 
 
 
 
 
Table: 2 Calculations to determine contralateral and ipsilateral functional deficit. 
 
 
 
 
Contralateral function = 
	 	 	
	 	
 
 
Ipsilateral function = 
	 	 	
	 	
 
Contralateral deficit = 1− 
contralateral function  
 
Ipsilateral deficit = 1− ipsilateral 
function 
Total deficit = Contralateral function + ipsilateral function 
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2.11 FUNCTIONAL RECOVERY CALCULATION FOR POST-STROKE 
DAY- 30: 
 
Table 3: Calculation of Contralateral and ipsilateral recovery on post-stroke day 30. 
 
2.12 FUNCTIONAL RECOVERY CALCULATION FOR POST-STROKE 
DAY-60: 
 
Table 4: Calculation of Contralateral and ipsilateral recovery on post-stroke day 60. 
 
 
 
Contralateral recovery = Contralateral function (PSD30) – Contralateral function 
(PSD3) 
Ipsilateral recovery = Ipsilateral function (PSD30) – Ipsilateral function (PSD3) 
Total recovery = Ipsilateral recovery + Contralateral recovery 
Contralateral recovery = Contralateral function (PSD 60) – Contralateral function 
(PSD3) 
Ipsilateral recovery = Ipsilateral function (PSD 60) – Ipsilateral function (PSD3) 
Total recovery = Ipsilateral recovery + Contralateral recovery 
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2.13 EUTHANIZATION AND CARDIOPERFUSION: 
 After 60 days of post-stroke study, the animals were euthanized. Each animal 
was taken separately into the surgery room and euthanization was performed. The 
animal was administered with euthasol (100mg/kg pentobarbital) via intraperitoneal 
injection. Once the animal has reached the surgical plane of anesthesia, 5-6 cm lateral 
incision was made just beneath the rig cage (94). Then the perfusion was initiated by 
inserting catheter into the left ventricle of the heart while flowing phosphate buffered 
saline (PBS) and the right atria was cut to drain the blood from the body. Once the 
blood was sufficiently removed from the body, then the solution was switched to 4% 
formaldehyde in PBS to fix the tissues and it was kept until 150ml of solution flushed 
through the heart. Next, the rat’s head was decapitated and dissected and the brain 
was stored in the 4% formaldehyde solution overnight. After 24 hours, the brain was 
transferred to 30% sucrose solution for three days. 
 
2.14 CRYOSTAT SECTIONING OF THE BRAIN: 
 The brain tissue was removed from the sucrose solution and was prepared for 
the cryostat by placing them into the block using optimal cutting temperature (OCT) 
compound in combination with a freezing peltier device. We waited until 30 minutes 
for the tissue and compound to reach the same temperature of the chamber 
temperature (−25°C) so that the tissue can be sliced without damage. Next, the brain 
was sectioned into coronal slices of 50μm in thickness. The tissues were sliced until 
the infarct region was seen in the right hemisphere. The collected slices were stored in 
the four vials containing phosphate buffer solution, each labeling them as DCX, ki67, 
infarct and control respectively.  
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2.15 DOUBLECORTIN STAINING: 
 The following protocol was followed for the staining of DCX. The brain slices 
for DCX were kept in the vials marked 1 and the control was kept in the vials marked 
4. 
 
 The PBS was removed from the vials and was replaced with 1.5 ml of 
blocking solution (PBS 0.3% with tween and 3% goat serum). The vials were 
incubated for one hour. 
 Next was the primary antibody incubation step. In this step, vials 1 were added 
with 1:400 dilution (3.75L) of doublecortin antibody (DC #4604 cell 
signaling) into the existing blocking solution. The primary antibodies were not 
added in the control vials 4. The vials were then taken to the cold room and 
were kept in shaker overnight at 5°C. 
 The next morning the vials were brought back to the room temperature and 
unbound antibodies were removed by washing the vials 1 twice with PBS-
Tween. 
 Subsequently, the second wash solution was replaced with 1.5 ml of the block 
solution in the vials 1. Then the vials 1 and 4 were added with 7.5L of 
biotinylated secondary antibody (goat-anti-rabbit-IgG) from vector ABC kit 
and were incubated for an hour. 
 At the end of the secondary antibody incubation, the vials were washed twice 
with PBS-Tween. Then 1.5 ml of ABC solution (avidin and goat-anti-rabbit-
IgG labeled with horse-radish peroxidase) were added to the vials and washed 
off with PBS-Tween twice after 30 minutes of incubation. 
 Finally 1.5 ml of DAB substrate were added to the vials 1 and washed off with 
	 21	
distilled water after five minutes. Then the vials were replaced with phosphate 
buffer saline solution. 
 After all the substrate was developed, tissues from vials 1 and 4 were ready to 
mount onto slides. 
 
2.16 TISSUE MOUNTING: 
  After the immunostaining protocol the vials 1 and 4 were emptied onto to a 
petri dish with PBS. The sections were carefully mounted onto the gel-coated 
slides using a thin paintbrush. Each slide was mounted with five sections and we 
thoroughly checked for any folding or tearing. Once the slides were dry, DPX 
mountant was put over the sections to preserve the staining and finally coverslip 
was placed on top to cover all the sections in the slide. 
2.17 MICROSCOPY AND IMAGE ANALYSIS: 
 The slides were observed via bright field microscopy using a 4X objective 
lens to capture the DCX staining along the regions of anterior, middle and posterior 
subventricular zone. The DCX staining were captured via digital microscope and 
were montaged using Adobe Photoshop. All the images were stored and categorized 
by animal number and were later keyed to either DCX control or DCX rehab. 
 A software program called imageJ was used to quantify the amount of 
neurogenesis in the subventricular zone. First, the program calibration was set as the 
microscope picture (area in mm2), DCX staining was outlined and threshold was 
adjusted. This was saved as mask of the original image and by using free hand tool 
redundant spots were removed. Simultaneously, the values for the area of the mask 
were stored in the excel sheet. The values from image J were then added up together 
and averaged to get an average area of neurogenesis for one rat. 
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2.18 STATISTICAL ANALYSIS: 
 Statistical analysis was done using the Graphpad prism 7 software and Sigma 
plot. To analyze the statistical difference between the groups unpaired t-test with 
Welch’s Correction and contingency test was performed using the Graph pad prism. 
Two-way ANOVA was plotted using the sigma plot. 
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III. RESULTS 
 
 In this study, there were 24 rats initially and we grouped them into two 
groups: control with rehabilitation and control without rehabilitation. Ischemic stroke 
surgery was performed in all the 24 rats using the vasoconstrictor, endothelin-1. The 
surgery was effective in both the groups and all the animals survived except one 
animal in the control with rehabilitation group.  
 
 
Table: 5 This table summarizes the number of rats in each group. 
Number of animals Control without 
Rehabilitation (Control) 
Control with 
rehabilitation 
(Rehab) 
Before the Surgery 12 12 
After the surgery 12 11 
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3.1 MONTOYA STAIRCASE TRAINING ANALYSIS: 
3.1.1 Pre-stroke rat weight analysis 
 The rat’s weight was measured for both the control and rehab groups from the 
beginning of the study until post-stroke day 60. The initial rat weights were compared 
statistically using the t-test (Welch’s correction for an unequal variance) between the 
two groups and the graph is shown below. 
 
Figure 6: Graph shows the comparison of pre-stroke rat weights. The blue bar in the 
X-axis denotes the control group and the red bar denotes the rehabilitation group. 
The Y-axis denotes mean weight in grams. t-test using Welch’s correction for an 
unequal variance was performed and the error bar indicates the standard error of the 
mean (SEM). 
 
From the above figure 5, we can observe that there is a significant difference 
between the two groups (P value = 0.021). The mean and SEM for the control group 
is 341.6 ± 6.277, n=12 and the mean and SEM for the rehab group is 318.9 ± 6.577, 
n=11. The rats that consumed more amount of peanut butter were chosen for the rehab 
study and were grouped accordingly. But it happened by chance that the control group 
Control Rehab
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weighed more than the rehab animals. This might be because of the rats in the rehab 
group did not eat rat chow and consumed more peanut butter when they were hungry. 
The initial grouping of the rats was based upon the consumption of the peanut butter 
but was not based on the animal’s weight. 
3.1.2 Post-stroke rat weight analysis 
 The rat’s weight was finally recorded at the post-stroke day 60, to analyze if 
there was any significant difference in the weights of the two groups over time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Comparison of final rat weights at post-stroke day 60. The X-axis denotes 
two groups: control and rehab. The blue bar in the X-axis denotes the control group 
and the red bar indicates the rehab group. t-test using Welch’s correction was 
performed statistically to compare between the both groups. Y-axis represents the 
mean weight in grams. The error bar represents the standard error of the mean 
(SEM). 
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The figure 6 shows that there was no significant difference between the 
control and the rehab group (P-value =0.0870). The mean and SEM for the control is 
356.3 ± 7.354, n=12 and the mean and SEM for the rehab is 339.6 ± 5.578, n=11. 
Here, we can note that significant difference seen in the pre-stroke rat weights in 
figure 5 went away over time, which may have had something to do with the rehab 
animals eating the fat peanut butter. 
3.1.3 Control Animals Weight Over Time: 
Figure 8: This graph is showing the control rat weights from the beginning of the 
study until the post-stroke day 60. Patterned blue bars in the X-axis denote different 
time points in the control study. Y column indicated the mean weight in grams and the 
error bars represent standard error of mean. One-way ANOVA was done to analyze 
statistical difference of the weights over time. 
 
The rat weights were measured every week throughout the study. From the 
above figure, we can see that there was no significant difference over time in the 
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control group as the P-value = 0.6441. This explains that there was no weight loss 
after the stroke induction (6/1, 6/2, 6/3) in the control group and the weights remained 
stable over time. 
 
3.1.4 Rehabilitation animals weight over time: 
 
Figure 9: This graph is showing the One-way ANOVA analysis of the rehab rat 
weights from the beginning of the study until the post-stroke day 60. Patterned red 
bars in the X-axis denote different time points in the rehab study. Y column indicates 
the mean weight in grams and the error bars represent standard error of mean. 
 
In figure 8, shows the rehabilitation weight measured every week from the 
beginning of the study until the post-stroke day 60. One-way ANOVA was performed 
with the data and the P-value = 0.0288, which shows a significant difference over 
time. At the beginning of the study, rehab rats weighed significantly lesser than the 
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control rats. This figure explains that the rehab rats have increased their weight over 
time by eating a sufficient amount of peanut butter and rat chow until they got stable 
at the end of the study. This also shows that the restricted diet during the Montoya 
staircase did not affect the weight of the rats. There is a slight decrease on the weight 
of the rats between 5/31 to 6/7, which might be due to the stroke surgery, which was 
performed on 6/1, 6/2, 6/3 and their weights increased during the rehabilitation study 
which started on post-stroke day 8 for all groups. Rehabilitation study began after the 
completion of the baseline Montoya staircase deficit following the stroke (post stroke 
days 3-5). 
 
3.2 FUNCTIONAL RECOVERY ANALYSIS: 
The rats were trained daily for 1.5 weeks for pre-stroke function analysis. The 
number of pellets retrieved by each rat from the wells were recorded to determine the 
baseline pre-stroke function. The best performance from the last three days of training 
was recorded as the baseline pre-stroke function. This number was then used as a 
gauge level to determine functional deficits and functional recovery in the post-stroke 
animals. The rats were tested on the staircase to record their initial functional deficit 
at 3-5 days of post-stroke and every 30 days (post stroke days 28, 29 and 30; post 
stroke day 58, 59 and 60) post-stroke for functional recovery. 
 
 
 
 
 
 
	 29	
3.2.1 Unilateral and Bilateral deficits 
  
  
Figure 10: Contingency test was statistically performed to compare the animals in 
each group with unilateral or bilateral deficits following the stroke induction. The X-
axis denotes two groups: bilateral or unilateral deficit; blue bar indicates the control 
group and the red bar indicates the rehab group. The Y-axis represents the number of 
animals. The graph shows no statistical difference between the groups, P=1(Fisher’s 
exact test). 
 
At post-stroke day 3, the animals were tested for unilateral or bilateral deficits. 
If the number of pellets retrieved by the rats after the surgery decreased from the 
baseline value, then it is said to have a functional deficit. If they showed a decrease in 
both contralateral and ipsilateral side, then deficits were bilateral. The above graph 
shows the contingency test comparing two groups for the unilateral or bilateral 
deficits, where P=1 (Fisher’s exact test) showing no statistical difference between the 
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groups. There were 23 animals after the surgery and 3 animals in the control and 
rehab group were affected with the bilateral deficit, 9 animals in the control group and 
8 in the rehab group had a unilateral deficit. The bilateral deficit may have occurred 
due to an error in the surgical procedures, endothelin might have damaged the corpus 
callosum. 
3.2.2 Contralateral Functional Analysis 
 To calculate the contralateral function, the number of pellets retrieved on a 
post-stroke day were divided by the pre-stroke baseline number of pellets to give the 
normalized function for that limb. The below graph shows the contralateral function 
between control and rehab groups at post-stroke day 3, 30 and 60.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Comparison of contralateral function between control and rehab over 
time. The X-axis denotes post-stroke day 3, 30 and 60. The red bar in the X-axis 
indicates the rehab group and blue bar represents the control group. The Y-axis 
denotes the contralateral function. Two way ANOVA was statistically done. 
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In figure 10, two way repeated measures ANOVA was performed and the 
statistically significant difference were seen between the post-stroke day 3 and 30, 
post-stroke day 3 and 60 for both control and rehab groups, where P value = <0.001. 
On post-stroke day 3-5, the contralateral function mean value for control was 0.237 
(23.7%) and rehab was 0.346 (34.6%). This signifies that the functional deficit 
following the stroke induction for the control group was about 76.3% and 65.4% for 
the rehab group. On post-stroke day 28-30, the animals recovered more than 50% of 
their contralateral function. The mean value for the control group was 0.784 and the 
rehab group was 0.667. On post-stroke day 58-60, the control animals had the 
contralateral function mean value of  0.774 (77.4%) and rehab animals mean value 
was 0.609 (60.9%). However, there was no overall significant difference seen 
between the control and rehab groups for the contralateral function. 
 
3.2.3 Ipsilateral Functional Analysis 
To analyze the ipsilateral function, the number of pellets taken on a given 
post-stroke day were divided by the pre-stroke number of pellets to give the 
normalized value for ipsilateral function. The below graph shows the ipsilateral 
function between control and rehab groups at post-stroke day 3, 30 and 60. 
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Figure 12: Results from the Montoya staircase training for the ipsilateral function 
between control and rehab over time. The X-axis denotes post-stroke day 3-5, 28-30 
and 58-60. The red bar in the X-axis indicates the rehab group and blue bar 
represents the control group. The Y-axis denotes the ipsilateral function. Two way 
ANOVA was statistically done and the error bar represents SEM. 
 
Two way repeated measures ANOVA was performed to compare the 
ipsilateral function between control and rehab over time. The data for the ipsilateral 
function failed the normality test (Shapiro-Wilk). There was no statistically 
significant difference seen between the groups or with respect to time. At post-stroke 
day 3-5, the mean value for the control group was 0.822 (82.2%) and the rehab group 
was 0.927 (92.7%). This implies that the ipsilateral function was not affected much 
with the surgery, animals had less than 20% deficit for both control and rehab groups. 
On post-stroke day 28-30, there was a slight decrease in the rehab group, 
which showed a mean value of 0.822 and an increase in the control group with the 
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mean of 0.917. Finally, at post-stroke day 58-60, the control animals almost recovered 
with the mean value of 0.996 (99.6%) and the rehab group displayed an increase with 
the mean of 0.870 (87%). 
 
3.2.4 Contralateral Recovery 
 To analyze and calculate the contralateral final recovery, the normalized 
contralateral function on the current day of testing (indicated on the X-axis) subtracts 
the normalized contralateral function on post-stroke day 3. The below figure shows 
the results from the Montoya staircase contralateral recovery. 
 
Figure 13: This graph compares the contralateral functional recovery on the post-
stroke day 30 and 60 based on the deficit 3-5 post-stroke days. Two-way repeated 
measures ANOVA was done. The X-axis denotes the post-stroke day 30 and 60. Blue 
bar indicates the control group; red bar denotes the rehab group. The Y-axis 
represents the contralateral recovery and the error bars displays the SEM.  
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From the figure 12, we can observe that there is a statistically significant 
difference between the control and the rehab group at both post-stroke day 30 and 60 
as the P value = 0.023. The contralateral recovery for the control group was 
significantly higher than the rehab group, where the mean value of control at post-
stroke day 30 was 0.542 (54.2%) and rehab was 0.346 (34.6%). This implies that the 
animals in the control group regained their contralateral function more effectively 
than the rehab group. At post-stroke day 60, the control group regained about 53% of 
the contralateral function and the rehab group regained only 27% of their contralateral 
function. 
 
3.2.5 Ipsilateral Recovery 
 To calculate the ipsilateral final recovery, the normalized ipsilateral function 
on the current day of testing (indicated on X-axis) subtracted the normalized 
ipsilateral function post-stroke day 3. The below figure shows the results from the 
Montoya staircase ipsilateral recovery. 
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Figure 14: Comparison of the ipsilateral functional recovery on the post-stroke day 
30 and 60 based on the deficit 3-5 post-stroke days. Two-way repeated measures 
ANOVA was done. The X-axis denotes the post-stroke day 30 and 60. Blue bar 
indicates the control group; red bar denotes the rehab group. The Y-axis represents 
the ipsilateral recovery and the error bars displays the SEM.  
 
 
In figure 12, two-way ANOVA was statistically done to compare ipsilateral 
functional recovery on the post day 30 and 60. The data failed the normality test 
(Shapiro-Wilk), no significant difference was seen between the two groups for the 
ipsilateral recovery (P value = 0.702). At post-stroke day 30, the mean value for the 
control group was 0.121 and the rehab was 0.0863. At post-stroke day 60, the control 
animals mean value was 0.173 and rehab was 0.060. 
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3.2.6 Total Post-stroke Recovery 
 
Figure 15: Total recovery analysis between control and rehab groups on the 
contralateral and ipsilateral sides at post-stroke day 30 and 60. Two way ANOVA 
was done. The X-axis represents the post-stroke day 30 and 60; the blue bar indicates 
the control and red bar indicates the rehab group. The Y-axis represents the total 
recovery. The error bar indicates SEM. 
  
The total recovery was calculated by adding the contralateral and the 
ipsilateral recovery from the post-stroke days 30 and 60. The total recovery results 
were shown in figure 14, we can observe that there was a significant difference 
between the control and rehab groups (P-value = 0.036). The total recovery for the 
control group showed an increase from the post-stroke day 30 (mean = 0.663; 66.3%) 
through the post-stroke day 60 (mean = 0.704 70.4%). Whereas the total recovery for 
the rehab group showed a slight decrease from the post-stroke day 30 (mean = 0.411 
41.1%) through the post-stroke day 60 (mean = 0.341 34.1%). 
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3.3 DOUBLECORTIN STAINING ANALYSIS: 
 The stained images were captured via bright field microscopy using a 4X 
objective lens. The DCX staining along the regions of anterior, middle and posterior 
subventricular zone was analyzed and measured using the quantitative tool called 
Image J software. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Image showing control DCX staining (no primary antibody, plus 
secondary antibody) in a control animal. Scale bar:500μm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: Image showing DCX positive cells in the subventricular region (plus 
primary antibody, plus secondary antibody) of a control animal. Scale bar: 500μm 
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Figure 18: Image showing the control DCX staining (no primary antibody, plus 
secondary antibody) in a rehab animal. Scale bar:500μm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Image showing DCX positive cells (plus primary antibody, plus secondary 
antibody) in the subventricular zone of a rehab animal. Scale bar:500μm 
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3.3.1 Doublecortin levels in the Anterior SVZ region 
 To estimate the DCX levels in the anterior subventricular zone, coronal slices 
were captured with the digital camera and the area of DCX was calculated using 
Image J. The staining was often seen on both sides of the ventricle. In the coronal 
slices (Figure 19) below, we can see a tear-shaped opening in the anterior SVZ. 
 
A)                                                                         B)
              
 
 
 
 
                                                                    
 
       
C) 
 
 
 
 
 
 
 
 
 
 
Figure 20 (A-C): Representing images showing DCX positive immunostaining of the 
anterior SVZ. Scale bar:500μm 
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Figure 21: Graph showing the analysis of DCX levels in the anterior SVZ for control 
and rehab animals. The blue bar (control; N=12) and the red bar (rehabilitation; 
N=11). The Y-axis indicates DCX area in mm2. T-test with Welch’s correction for 
unequal variance was done (P=0.3376). The error bar indicates SEM. 
  
 Figure 20 shows the average area of DCX positive cells in the anterior portion 
of the subventricular zone for the control and the rehab groups. There was no 
significant difference seen between the groups ( P=0.3376). The mean and SEM of  
the control group was 0.006038 ± 0.0005053 and the mean and SEM of the rehab 
group was 0.008805 ± 0.00271. 
From the figure 20, there was an outlier identified using ROUT method  
(Q =1%). The cleaned data removed one value from the rehab group and the graph 
was performed using T-test with Welch’s correction for unequal variance. There was 
no statistically significant difference after the outlier was removed (P=0.7839). The 
mean and SEM value for the control was 0.006038 ± 0.0005053, n=12 and the rehab 
was 0.006505 ± 0.001585, n=10. 
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Figure 22 : Graph showing the analysis of DCX levels in the anterior SVZ after 
removing outliers from the data. T-test with Welch’s correction for unequal variance 
was performed (P=0.7839) 
 
3.3.2 Doublecortin levels in the Middle SVZ region 
 
 
A) 
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B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23(A-B): Representing images showing DCX positive immunostaining of the 
middle SVZ. Scale bar:500μm 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: Graph showing the analysis of DCX levels in the middle SVZ for control 
and rehab animals. The blue bar (control; N=12) and the red bar (rehabilitation; 
N=10). The Y-axis indicates DCX area in mm2. T-test with Welch’s correction for 
unequal variance was done (P value = 0.1039). The error bar indicates the SEM. 
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From the figure 22, we can observe that the ventricles in the middle region of 
the SVZ have opened up and the DCX staining was mostly seen on the side of the 
ventricle away from the midline. T-test with Welch’s correction was performed 
statistically (figure 23) to compare neurogenesis (DCX) levels on the middle region of 
SVZ between control and rehab groups. There was no significant difference  
(P value = 0.1039) between the groups. The mean and SEM for the control group was 
0.005159 ± 0.0004208, n=12 and the rehab group was 0.01029 ± 0.00282, n=10 
 
3.3.3 Doublecortin Levels In The Posterior SVZ Region 
A) B) 
                                                                    
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: A-C ): Representing images showing DCX positive immunostaining of the 
posterior SVZ. Scale bar:500μm 
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Figure 26: Graph showing the analysis of DCX levels in the posterior SVZ for control 
and rehab animals. The blue bar (control; N=12) and the red bar (rehabilitation; 
N=11). The Y-axis indicates DCX area in mm2. T-test with Welch’s correction for 
unequal variance was done (P = 0.2263). The error bar indicates the SEM. 
 
To analyze the DCX staining in the posterior region of the SVZ, t-test with 
Welch’s correction was statistically performed to compare the average area of the 
posterior SVZ in both the control and rehab animals. No statistical significant 
difference (P = 0.2263) was found between the groups. The mean and SEM value for 
the control group was 0.003437 ± 0.0004994, n=12 and the rehab was 0.005757 ± 
0.001746, n=11. 
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3.3.4 Total mean area (DCX) of Subventricular zone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27: Analysis of total anterior, middle, posterior regions of SVZ for control 
and rehab groups. Each of the blue dots (control; N=12) and the red dots (rehab 
N=11) represents a single animal. T-test with Welch’s correction was statistically 
done (P-value = 0.2272). Y-axis indicates the DCX area mm2 and the error bar 
represents SEM. 
 
The total mean of anterior, middle and posterior regions of SVZ for both the 
control and rehab groups were analyzed and compared using t-test with Welch’s 
correction (Figure 26). No statistically significant difference (P value = 0.2272) was 
found between the groups although the rehab group showed a higher mean value 
compared to the control group. The mean and SEM for the control group was 
0.005358 ± 0.0003567, n=12 and the rehab was 0.008517 ± 0.002436, n=11. 
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3.3.5 Comparing Different Regions of Subventricular Zone 
 
Figure 28: Comparison of different regions (anterior, middle, posterior) of the 
subventricular zone for the control and rehab group. X-axis denotes the different 
regions of SVZ for the control (blue) and the rehab (red) group. Two-way ANOVA 
was statistically performed, P=0.018. The error bars indicates the SEM. 
 
The different regions (anterior, middle, posterior) of the subventricular zone 
were statistically compared using the two-way ANOVA. There was a significant 
difference between the control and the rehab groups (P-value = 0.018) but not with 
respect to the different regions. This signifies that the rehab group has a significant 
increase in the stem cell proliferation compared to the rehab group overall.
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IV. DISCUSSION 
 
4.1 OVERALL RAT WEIGHT SUMMARY:  
 Initially, in the pre-stroke rat weight analysis, we saw a significant difference 
between the control and the rehab group (Figure 5). The rat’s weight were measured 
every week throughout the study to monitor their health conditions. The rats that 
consumed more peanut butter were considered for the rehabilitation study. But 
unfortunately, the control animals weighed more than the rehab group, when this 
initial assignment was made. This might be because the animals in the rehab group 
did not eat as much rat chow and consumed more peanut butter when they were 
hungry. The initial animal grouping was purely based on the consumption of peanut 
butter but not based upon the animal’s weight. 
 The post-stroke results showed no significant difference between the control 
and the rehab groups as regards weight. This indicates that the animals in the rehab 
group gained their weight after the stroke surgery, which was performed on the days 
6/1, 6/2, 6/3. Moreover, this also signifies that the rats used their forelimb to consume 
more peanut butter (beginning post-stroke day 8) and due to the high-fat diet, we saw 
an increase in the weights in the post-stroke rat analysis (Figure 6). The animals did 
not lose any weights during the Montoya staircase testing and remained consistent 
over time. 
 Overall, the control animals weight history from day 5/31 (pre-stroke) through 
7/20 (at the end of the study) showed no significant difference (Figure 7). This 
indicates that the there was no weight loss after stroke induction and the weight 
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remained stable over time. Furthermore, the rehab animals weight history from day 
5/31 through 7/20 showed a significant increase in the animal weights (Figure 8). The 
significant difference may have resulted due to rehab animals weighing less initially 
(pre-stroke) and the statistical difference was seen with respect to the time (between 
6/7- 6/15) after stroke induction. The fat content in the peanut butter may have 
increased the weight in the rehab animals, showing this statistical difference over the 
time period (Figure 8). Studies have shown that rats fed with high-fat diet increases 
weight and fat tissue mass gain in rats (104). 
 
4.2 VOLUNTARY PHYSICAL REHABILITATION: 
 The rehabilitation for the animals started at post-stroke day 8 and continued 
for a total of 23 days. The rehab shelves were filled with peanut butter and were hung 
outside the cages so that the rats can use their contralateral forelimb to grab the peanut 
butter voluntarily. The rehab was held every-day except during the functional testing 
days. The average amount of peanut butter consumed by the rats and the average 
number of arm swipes a rat achieved every-day was also measured. The below graphs 
(Figure 30 and Figure 31) was acquired from the same study by Ms. Devipriyanka 
Nagarajan (97), illustrates the linear regression analysis to determine the amount of 
peanut butter consumed by animals per day and the average amount of peanut butter 
consumed per arm swipe. 
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Figure 29: The linear regression analysis shows the amount of peanut butter 
consumed by rehab animals throughout the study (97). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30: The linear regression analysis shows the average amount of peanut butter 
per forelimb swipe throughout the rehabilitation days (97). 
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 From the above Figure 28 and Figure 29, we can clearly see that the 
amount of peanut butter consumption and forelimb swipes per day decreased as the 
rehab days increased in the study. The rehabilitation procedure began 8 days after the 
onset of stroke, the animals were given a sufficient amount of time to reconcile from 
the stroke injury. So the best possible explanation for the decrease in the consumption 
of peanut butter and forelimb movement might be due to physical stress. Post-stroke 
physical stress can lead to depression which in turn affects the functional recovery 
and cognitive function (95). The previous stroke study from our laboratory showed a 
better recovery in the rehabilitation animals compared to the control group. The 
previous rehab study was carried for 90 days with a rest period of 30 days before 
euthanization and also only about one-fourth of the peanut butter was hung when 
compared to our study (96). Whereas in the current study, the animals were 
consuming an excessive amount of peanut butter by using their forelimb which might 
have caused physical stress and fatigue in the animals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31: Image showing trough filled with peanut butter from our previous lab 
study (96). 
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Figure 32: Image showing trough filled with peanut butter from our current lab 
study. 
  
This demonstrates that the repetitive use of impaired forelimb have caused 
physical stress in the animals. Higher BDNF concentration in the hippocampus region 
is related to motor and functional recovery in animal models. Research studies have 
shown that excessive amount of exercise can lead to down-regulation of BDNF. In 
addition, corticosterone (CORT) a biomarker used for evaluating stress in animal 
models, have shown to down-regulate BDNF and increased stress levels (100). Thus 
by analyzing brain BDNF and plasma CORT in our study, we can compare the 
relationship between motor recovery and stress in animals. The concentration of 
BDNF and CORT can be evaluated using an enzyme-linked immunosorbent assay 
(ELISA) (101,102), but we would have done this in the subventricular zone. Overall, 
we can say that the intensity of a training plays a key role in the rehabilitation and 
thus the training should be gradually increased to benefit from the rehabilitation 
outcome. 
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4.3 FUNCTIONAL RECOVERY 
 
4.3.1 Bilateral deficits and ipsilateral functional recovery 
 After the stroke induction, the animals were tested for bilateral and unilateral 
deficits on post-stroke day 3. There are some animals that showed functional deficit 
on both contralateral and ipsilateral sides (Figure 9). This might have occurred due to 
the surgical errors, hitting the wrong coordinates or ET-1 reaching the corpus 
callosum which connects to the right and left hemisphere of the brain, damaging both 
contralateral and ipsilateral sides leading to the bilateral deficits.  
The ipsilateral function was not affected much with the surgery, animals had 
less than 20% deficit for both control and rehab groups. At post-stroke day 58-60, the 
ipsilateral function for the control group showed a recovery of about 99.6% and the 
rehab group displayed an increase with 87%. Although there was no significant 
difference seen with respect to time or groups, we can see that the animals with the 
bilateral deficits showed a substantial increase in ipsilateral function. The ipsilateral 
function almost recovered in control group and bilateral deficits essentially faded at 
post-stroke day 60. This implies the impromptu recovery of white matter tracts in the 
control and the rehab groups (98,99)  
Furthermore, a correlation between Ki67 and ipsilateral functional recovery 
from the same study (97) illustrated a strong correlation and significance with the P 
value of 0.0007 in the control groups. This correlation shows an enhanced recovery in 
the white matter (Figure 32). In contrast, Figure 33 illustrated a correlation between 
Ki67 (neurogenesis) and ipsilateral functional recovery in rehab animals and showed 
no correlation between them. This might be due to the reduction of stem/progenitor 
cells which in turn have caused due to the stress in rehab animals (97). 
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Figure 33: Image showing correlation between Ki67 total area mm2 and ipsilateral 
functional recovery in the control group (97).  
 
 
 
 
Figure 34: Image showing correlation between Ki67 total area mm2 and ipsilateral 
functional recovery in the rehab group (97). 
 
  
In contrast, my results showed a better correlation between DCX staining and 
ipsilateral functional recovery in rehab and control animals. This is because DCX 
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immunoreactive cells are highly expressed over 2-3 week after the ischemic injury but 
Ki67 are expressed at a particular period. Thus Ki67 total area mm2 showed no 
correlation with the ipsilateral functional recovery while DCX staining should have 
shown a correlation. 
  
4.3.2 Contralateral functional recovery: 
 The results of this study demonstrated that the functional recovery was 
significantly higher in the control group (contralateral side) compared to the rehab 
group (Figure12). At post-stroke day 30 and 60, the contralateral function for the 
rehab group and the control group showed a significant increase with respect to time. 
The contralateral function on post-stroke day 58-60 in the control group displayed an 
increase of 77.4% while the rehab group only showed an increase of 60.9%. 
This study demonstrated a significant difference in the contralateral functional 
recovery between the control and rehab groups. The control group displayed a higher 
contralateral functional recovery of about 53% and the rehab group regained only 
about 27% at post-stroke day 60. We saw a 10% decrease in the contralateral 
functional recovery in the rehab animals with respect to post-stroke day 30. Whereas 
the control group contralateral recovery remained stable after post-stroke day 30. 
Furthermore, we also saw a significant difference in the total recovery in the 
control and rehab groups. The control group recovered better with an increase of 
70.4% and the rehab group regained only about 34.1% of their total recovery. These 
results explain that the control animals displayed a better functional recovery 
compared to the rehab animals. In our previous study, rehab animals recovered better 
compared to the control animals. The contralateral function for the rehab group was 
26% and the control group was 8.6% on post-stroke day 90. Although physical 
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rehabilitation did not show any correlation with the functional recovery, there was a 
steady statistical trend (96).  
From the graph (Figure 34) we can explain that there is no strong correlation 
between the physical rehabilitation (measured by arm swipes) and the total functional 
recovery (97). As the arm swipes increase the total functional recovery decreased in 
some of the animals. This might be the result of physical stress (increased CORT 
levels) in the rehabilitation animals. We hypothesized to see increased functional 
recovery correlated with the voluntary physical rehabilitation. However, we saw no 
correlation between them. Physical rehabilitation did not result in increased functional 
recovery. 
 
 
 
 
 
 
 
 
 
 
 
Figure 35: Graph showing correlation between the arm swipes and the total 
functional recovery. Each dots represents a single animal (97). 
 
4.4 NEUROGENESIS: 
 In our study, doublecortin (DCX) was used as a neuronal marker for 
measuring neurogenesis after ischemia. We studied all the three regions (anterior, 
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middle, posterior) of the subventricular zone in the rat brain. Although we did not see 
a significant difference between the control and the rehab groups, the rehab group 
emphatically showed a higher mean value in all the three SVZ regions compared to 
the control groups (Figure 21, Figure 23 and Figure 25). Likewise, there was no 
significance seen between the control and the rehab groups for the total mean of the 
SVZ doublecortin, but certainly the rehab group demonstrated a higher mean value 
compared to the control group (Figure 26). 
 Also, we compared all the three regions of the SVZ using the two-way 
ANOVA (Figure 27). We saw a significant difference between the rehab and the 
control group, where the rehab group showed a higher production of neurogenesis 
(DCX) compared to the control group.  
 
4.4.1 The Effects Of Stress On Adult Neurogenesis: 
 Some studies have shown that there is a reciprocal relationship between adult 
neurogenesis and stress in rodents. The stress modulators can affect adult 
hippocampal neurogenesis in the sub-granular zone (SGZ) which is the hippocampal 
neurogenesis niche (103). Although there are several modulators that induce stress 
including pro-inflammatory cytokines, neurotropic factor (BDNF) and morphogen 
signaling pathways, glucocorticoid is one of the key modulators for stress. Both acute 
and chronic stress in rats can predominately reduce neurogenesis, cell proliferation in 
the hippocampal region (103). 
 In our study, the potential reason for not displaying a statistically significant 
difference in the total SVZ region (DCX neurogenesis) between control and rehab 
might be due to the overuse of impaired forelimb during rehabilitation procedure. The 
overuse of forelimb has resulted in the stress which in turn affected the production of 
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neurogenesis in rats. We did not anticipate that the animals would voluntarily stress 
with overuse of impaired forelimb. 
 
 
 
 
 
 
 
 
 
Figure 36: Graph showing correlation between total arm swipes during 
rehabilitation and Ki67 area in mm2 (97). 
 
Figure 35 was acquired from the same study (97), the graph shows the 
correlation between the total arm swipes during rehabilitation and Ki67 (stem cell 
proliferation). This demonstrated that the increase in the forelimb swipes above 2000 
had triggered a negative impact on the stem cell proliferation (Ki67) in the 
subventricular zone (97). This is possibly due to the effect of stress from overdoing of 
physical rehabilitation. 
 
4.4.2 Effects of Estrogen on Neurogenesis and Functional Recovery After 
Ischemia: 
Many studies have shown that estrogen can increase the number of newborn 
neurons in the SVZ of an animal model and also undergo brain repair after ischemia. 
Estrogen expression is prominent in the pre-menopausal rats, which has shown 
	 58	
neuroprotective role and increase in the stem cell proliferation in some of the studies 
(75,104).  
In our study, we assume that some of the rats in the control group may still 
have estrogen expression (pre-menopausal) after ischemia. This can be one of the 
possible explanations for an increase in neurogenesis seen in the control group. 
Estrogen levels have to be tested to validate the results. Estrogen can be quantified 
using ESTRADIOL ELISA kit. 
 
4.5 FUTURE WORKS: 
 In the future study, some alterations are required to further investigate and 
validate the results. The levels of corticosterone need to be quantified in order to 
understand the stress response in animals. High levels of corticosterone can down-
regulate BDNF which decreases neurogenesis in rats. The concentration of BDNF and 
CORT can be evaluated using an enzyme-linked immunosorbent assay (ELISA) (100-
101). Since estrogen plays an important role in neuroprotection and increase in the 
stem cell proliferation, estrogen levels have to be evaluated to determine if the 
animals are post-menopausal. 
 Since rehabilitation was a major part of this study, rehab time and intensity of 
the exercise should be reduced to improve stress endurance and show better recovery 
in animals. The intensity of the exercise should be gradually increased in order to see 
better recovery without stress in animals. Furthermore, trough height and distance can 
be modified to strengthen recovery of impaired forelimb by making them use 
different postures. Also the amount of peanut butter given to the animals during 
rehabilitation should be reduced to avoid abrupt physical stress in animals. A gradual 
program of rehabilitation, with slow buildup of use of the arm would avoid physical 
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stress in the arm and would likely improve functional recovery.
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